Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988742445> ?p ?o ?g. }
- W1988742445 endingPage "1317" @default.
- W1988742445 startingPage "1311" @default.
- W1988742445 abstract "Background Today, treatment of chronic hepatitis C is based on a synergistic combination of pegylated interferon and ribavirin with antiprotease inhibitors. Haemolytic anaemia, which is the major side effect of ribavirin treatment, disrupts ribavirin treatment compliance and varies significantly from one patient to another. There is an individual susceptibility to ribavirin haemolysis. With a view to studying haemolysis, and thus optimizing the treatment response, we have developed a new in vitro tool for analysing the ribavirin-induced lysis of red blood cells. Methods Resuspended red blood cells were incubated with isotonic buffer and a range of concentrations of ribavirin. Haemolysis was quantified by spectrophotometric measurement of the supernatant at 540 nm. The assay was used to test the effects of various compounds and to investigate the susceptibility of patients to haemolytic anaemia. Results In our assay, the degree of haemolysis is dependent on the ribavirin concentration used and can be inhibited by the addition of dipyridamole (50% inhibitory concentration [IC 50 ] 30 μM), ATP or glutathione (IC 50 1.63 mM and 767 μM, respectively). We observed a strong decrease in red blood cell haemolysis in the presence of the ribavirin prodrug viramidine (Taribavirin®). When testing the performance of this assay with blood from 24 patients before treatment, we observed a strong correlation between in vitro haemolysis before treatment and the decrease in haemoglobin levels seen in vivo during subsequent treatment ( P<0.001). Conclusions With this new tool it is possible to better evaluate individual susceptibility to ribavirin-induced haemolysis before the start of treatment. In addition, this model will enable the mechanism of ribavirin-induced anaemia to be further explored and allow molecules that could reduce ribavirin haemolysis to be screened and tested in vitro. This approach could help optimize current and future therapeutic strategies involving ribavirin in the treatment of chronic hepatitis C." @default.
- W1988742445 created "2016-06-24" @default.
- W1988742445 creator A5009030222 @default.
- W1988742445 creator A5019119809 @default.
- W1988742445 creator A5021800720 @default.
- W1988742445 creator A5025664757 @default.
- W1988742445 creator A5037924047 @default.
- W1988742445 creator A5048635664 @default.
- W1988742445 creator A5062995036 @default.
- W1988742445 creator A5071757923 @default.
- W1988742445 creator A5090111306 @default.
- W1988742445 date "2012-10-01" @default.
- W1988742445 modified "2023-10-17" @default.
- W1988742445 title "A New Tool to Study Ribavirin-Induced Haemolysis" @default.
- W1988742445 cites W1972732919 @default.
- W1988742445 cites W1975105404 @default.
- W1988742445 cites W1976406734 @default.
- W1988742445 cites W1978339383 @default.
- W1988742445 cites W2014983544 @default.
- W1988742445 cites W2022700796 @default.
- W1988742445 cites W2027992424 @default.
- W1988742445 cites W2033753462 @default.
- W1988742445 cites W2035447021 @default.
- W1988742445 cites W2064546869 @default.
- W1988742445 cites W2077719713 @default.
- W1988742445 cites W2079002457 @default.
- W1988742445 cites W2080656840 @default.
- W1988742445 cites W2082408952 @default.
- W1988742445 cites W2084028300 @default.
- W1988742445 cites W2087655921 @default.
- W1988742445 cites W2089539469 @default.
- W1988742445 cites W2092710527 @default.
- W1988742445 cites W2099222314 @default.
- W1988742445 cites W2108624165 @default.
- W1988742445 cites W2109235725 @default.
- W1988742445 cites W2117269615 @default.
- W1988742445 cites W2169936170 @default.
- W1988742445 doi "https://doi.org/10.3851/imp2308" @default.
- W1988742445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22951364" @default.
- W1988742445 hasPublicationYear "2012" @default.
- W1988742445 type Work @default.
- W1988742445 sameAs 1988742445 @default.
- W1988742445 citedByCount "12" @default.
- W1988742445 countsByYear W19887424452013 @default.
- W1988742445 countsByYear W19887424452014 @default.
- W1988742445 countsByYear W19887424452015 @default.
- W1988742445 countsByYear W19887424452016 @default.
- W1988742445 countsByYear W19887424452017 @default.
- W1988742445 countsByYear W19887424452023 @default.
- W1988742445 crossrefType "journal-article" @default.
- W1988742445 hasAuthorship W1988742445A5009030222 @default.
- W1988742445 hasAuthorship W1988742445A5019119809 @default.
- W1988742445 hasAuthorship W1988742445A5021800720 @default.
- W1988742445 hasAuthorship W1988742445A5025664757 @default.
- W1988742445 hasAuthorship W1988742445A5037924047 @default.
- W1988742445 hasAuthorship W1988742445A5048635664 @default.
- W1988742445 hasAuthorship W1988742445A5062995036 @default.
- W1988742445 hasAuthorship W1988742445A5071757923 @default.
- W1988742445 hasAuthorship W1988742445A5090111306 @default.
- W1988742445 hasConcept C126322002 @default.
- W1988742445 hasConcept C150903083 @default.
- W1988742445 hasConcept C185592680 @default.
- W1988742445 hasConcept C202751555 @default.
- W1988742445 hasConcept C203014093 @default.
- W1988742445 hasConcept C207001950 @default.
- W1988742445 hasConcept C2522874641 @default.
- W1988742445 hasConcept C2776408679 @default.
- W1988742445 hasConcept C2776461080 @default.
- W1988742445 hasConcept C2776557347 @default.
- W1988742445 hasConcept C2779902561 @default.
- W1988742445 hasConcept C2780040827 @default.
- W1988742445 hasConcept C2910801743 @default.
- W1988742445 hasConcept C55493867 @default.
- W1988742445 hasConcept C71924100 @default.
- W1988742445 hasConcept C86803240 @default.
- W1988742445 hasConcept C98274493 @default.
- W1988742445 hasConceptScore W1988742445C126322002 @default.
- W1988742445 hasConceptScore W1988742445C150903083 @default.
- W1988742445 hasConceptScore W1988742445C185592680 @default.
- W1988742445 hasConceptScore W1988742445C202751555 @default.
- W1988742445 hasConceptScore W1988742445C203014093 @default.
- W1988742445 hasConceptScore W1988742445C207001950 @default.
- W1988742445 hasConceptScore W1988742445C2522874641 @default.
- W1988742445 hasConceptScore W1988742445C2776408679 @default.
- W1988742445 hasConceptScore W1988742445C2776461080 @default.
- W1988742445 hasConceptScore W1988742445C2776557347 @default.
- W1988742445 hasConceptScore W1988742445C2779902561 @default.
- W1988742445 hasConceptScore W1988742445C2780040827 @default.
- W1988742445 hasConceptScore W1988742445C2910801743 @default.
- W1988742445 hasConceptScore W1988742445C55493867 @default.
- W1988742445 hasConceptScore W1988742445C71924100 @default.
- W1988742445 hasConceptScore W1988742445C86803240 @default.
- W1988742445 hasConceptScore W1988742445C98274493 @default.
- W1988742445 hasIssue "7" @default.
- W1988742445 hasLocation W19887424451 @default.
- W1988742445 hasLocation W19887424452 @default.
- W1988742445 hasOpenAccess W1988742445 @default.
- W1988742445 hasPrimaryLocation W19887424451 @default.